{"id":"NCT00619359","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)","officialTitle":"A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel-Group Study, Conducted Under In-House Blinding Conditions, to Examine the Safety, Tolerability, and Efficacy of a Single Dose of Intravenous MK-0517 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated With Cisplatin Chemotherapy","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2008-02","primaryCompletion":"2009-06","completion":"2009-06","firstPosted":"2008-02-21","resultsPosted":"2010-02-12","lastUpdate":"2017-03-21"},"enrollment":2322,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"PREVENTION"},"conditions":["Chemotherapy-Induced Nausea and Vomiting (CINV)"],"interventions":[{"type":"DRUG","name":"Comparator: fosaprepitant dimeglumine","otherNames":[]},{"type":"DRUG","name":"Comparator: Aprepitant","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Dexamethasone","otherNames":[]},{"type":"DRUG","name":"Ondansetron","otherNames":[]}],"arms":[{"label":"1","type":"EXPERIMENTAL"},{"label":"2","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this study is to examine the safety, tolerability, and efficacy of MK0517 to prevent Chemotherapy-Induced Nausea and Vomiting (CINV) associated with Cisplatin chemotherapy.","primaryOutcome":{"measure":"A Complete Response (no Vomiting and no Use of Rescue Therapy) Overall (in the 120 Hours Following Initiation of Cisplatin).","timeFrame":"Overall (in the 120 hours following initiation of cisplatin chemotherapy).","effectByArm":[{"arm":"Fosaprepitant","deltaMin":795,"sd":null},{"arm":"Aprepitant","deltaMin":820,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":5},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["21383291"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":148,"n":1143},"commonTop":["Constipation","Asthenia","Diarrhoea","Anorexia","Nausea"]}}